… prostate cancer; and ongoing clinical trials aiming to improve treatment outcomes for advanced prostate cancer … hematologic profile, and drug-drug interactions, which … whether pre-chemotherapy or post-chemotherapy, and … the addition of abiraterone. We also …

… from a global phase 2 trial showing that a 250 mg … -term, large-scale, controlled clinical trial is essential to further evaluate … . Lower dose of abiraterone acetate as effective for prostate cancer treatment. News release. National …

… treatment in nondiabetic patients with metastatic hormone-sensitive prostate cancer … such as abiraterone (Zytiga), enzalutamide … prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial … Metastatic Prostate Cancer: Evaluation of Drug …

… fit seamlessly into various prostate cancer treatment scenarios, from unfavorable … especially relevant in modern prostate cancer care, where patients … medications like abiraterone or enzalutamide, adding an oral ADT simplifies the overall treatment …

… same month, Foundation Medicine secured FDA approval for FoundationOne®CDx … with Abiraterone for mCRPC. In May 2024, Fusion Pharmaceuticals launched … drugs for Metastatic Prostate Cancer to improve the treatment landscape. Promising Metastatic Prostate Cancer …

… 2 trial for metastatic castration-resistant prostate cancer in; … whose prostate cancer has progressed after standard hormone treatments. … (abiraterone), Xtandi (enzalutamide), or Nubeqa (darolutamide). Treatments like … by the study doctor. Patients cannot take …

… intensified treatment from therapeutic approaches like Zytiga (abiraterone) … prostate cancer will truly benefit from intensified treatment? What have recent trials … drug called Zytiga. Zytiga is approved for use in metastatic prostate cancer — prostate cancer …

… -endorsed treatments for metastatic castration-sensitive prostate cancer; [however … such as comorbidities, drug interactions, tolerability, and … trials. That said, with expanded use of electronic medical … alongside efficacy. Abiraterone requires daily steroids …

… ;s androgen blocker Zytiga (abiraterone), has been submitted for approval … to niraparib in prostate cancer, and views the drug as a successor … the phase 3 EvoPAR-PR01 trial. Meanwhile, Pfizer' … Xtandi (enzalutamide) as a treatment for patients with DNA …

… (abiraterone) to standard treatment for patients with high-risk, non-metastatic prostate cancer significantly … therapy drug called Zytiga. Zytiga is approved for use in metastatic prostate cancer — prostate cancer …